P

Inventor

HEIMBURGER NORBERT

37 patents
⚠️ This page may combine multiple inventors who share the name “HEIMBURGER NORBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BEHRINGWERKE AG

29 patents
US4297344AOct 27, 1981

Blood coagulation factors and process for their manufacture

BEHRINGWERKE AG212 citations97
US4650678AMar 17, 1987

Readily dissolvable lyophilized fibrinogen formulation

BEHRINGWERKE AG160 citations96
US5407671AApr 18, 1995

One-component tissue adhesive and a process for the production thereof

BEHRINGWERKE AG54 citations94
US4411794AOct 25, 1983

Process for the purification of the blood clotting factors, II, VII, IX and/or X

BEHRINGWERKE AG56 citations93
US5043428AAug 27, 1991

Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production

BEHRINGWERKE AG27 citations92
US4056484ANov 1, 1977

Stable blood plasma, process for preparing it and its use as comparative plasma in coagulation tests

BEHRINGWERKE AG41 citations92
US5057414AOct 15, 1991

Method for the determination of the activity of serine proteases or serine protease inhibitors

BEHRINGWERKE AG25 citations91
US4915945AApr 10, 1990

Process for the preparation of the C1 inactivator

BEHRINGWERKE AG29 citations90
US4960757AOct 2, 1990

Pasteurized human fibrinogen (HF), a process for its preparation, and its use

BEHRINGWERKE AG35 citations89
US4562072ADec 31, 1985

Process for the pasteurization of antihemophilic cryoprecipitate (AHC) and antihemophilic cryoprecipitate prepared thereby

BEHRINGWERKE AG20 citations81
US4405603ASep 20, 1983

Method for rendering factors IX and X hepatitis-safe with calcium ions

BEHRINGWERKE AG25 citations81
US4404187ASep 13, 1983

Method for rendering factors II and VII hepatitis-safe with a chelating agent

BEHRINGWERKE AG24 citations81
US4442213AApr 10, 1984

Process for the preparation of plasminogen and plasminogen thus prepared

BEHRINGWERKE AG20 citations80
US5136026AAug 4, 1992

Process for removing toxins from protein solutions

BEHRINGWERKE AG13 citations74
US4404134ASep 13, 1983

Collagen sponge

BEHRINGWERKE AG5 citations73
US4331766AMay 25, 1982

Collagen solution, process for its manufacture and its use

BEHRINGWERKE AG11 citations73
US5695753ADec 9, 1997

Transglutaminases as immunosuppressants

BEHRINGWERKE AG9 citations72
US5049545ASep 17, 1991

Insulin derivatives, a process for their preparation, and their use

BEHRINGWERKE AG11 citations72
US5464615ANov 7, 1995

Use of transglutaminases as immunosuppressants

BEHRINGWERKE AG11 citations71
US4106990AAug 15, 1978

Quantitative determination of antithrombin III

BEHRINGWERKE AG8 citations71
US4033824AJul 5, 1977

Process for the determination of plasminogen

BEHRINGWERKE AG6 citations69
US4178368ADec 11, 1979

Method for the treatment of thromboembolism

BEHRINGWERKE AG9 citations66
US4308204ADec 29, 1981

Process for preparing the third component of the complement from human blood plasma

BEHRINGWERKE AG3 citations63
US4067964AJan 10, 1978

Antihemophilic agent and process for its manufacture

BEHRINGWERKE AG4 citations62
US5091363AFeb 25, 1992

Agent for the therapy of factor viii-resistant hemophilia a, and a process for the preparation thereof

BEHRINGWERKE AG5 citations58
US4245039AJan 13, 1981

Stable clumping factor for the identification of fibrinogen and fibrin cleavage products and process for preparing it

BEHRINGWERKE AG5 citations57
US5607837AMar 4, 1997

Method for the determination of the plasminogen activator activity in samples containing alpha-2-antiplasmin

BEHRINGWERKE AG0 citations51
US5204256AApr 20, 1993

Process for the purification of plasminogen activator inhibitor 2 (pai-2)

BEHRINGWERKE AG1 citations48
US5512449AApr 30, 1996

Method for the functional determination of protein C inhibitor

BEHRINGWERKE AG0 citations40

AVENTIS BEHRING GMBH

3 patents

HOECHST AG

2 patents

BEHRINGWERKE AKTIENGESESCHAFT

1 patent

DADE BEHRING MARBURG GMBH

1 patent

BEHRINGWERKE AKITENGESELLSCHAF

1 patent